ARTICLE | Company News

Elan, ImaRx, Verion Inc. deal

February 5, 2001 8:00 AM UTC

ELN and ImaRx formed a joint venture to develop an oncology therapeutic using ImaRx’s HydroPlex drug delivery system, which wraps hydrophobic drugs with polymer strands to make them more water soluble and less toxic. ELN made an equity investment in ImaRx and provided a line of credit to fund the venture. ...